Clinical trial
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
NCT00002904 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002904 |
|---|---|
| Title | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors |
| Official title | PHASE I CLINICAL AND PHARMACOKINETIC STUDY TO DETERMINE THE SAFETY OF ECTEINASCIDIN-743 (ET-743) ADMINISTERED AS A SINGLE INTRAVENOUS INFUSION OVER 60 MINUTES EVERY 21 DAYS IN PATIENTS WITH SOLID TUMORS |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | trabectedin |
| Enrollment | 40 |
| Start date | Feb 1, 1996 |
| First posted | Sep 3, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Austria, Belgium, Denmark, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Portugal, Spain and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: